Comparison of the efficacy of magnessium sulphate and diazepam in the control of tetanus spasms

Scientific Research and Essays

Volumn 3, Issue 12, 2008, Pages 571-576

  Osalusi, B S ^a   Ogun, S A ^a   Ogunniyi, A ^b   Kolapo, K O ^a  

^a OLABISI ONABANJO UNIVERSITY   (Nigeria)

^b UNIVERSITY OF IBADAN   (Nigeria)

Author keywords

Diazepam; Magnesium sulphate; Tetanus spasms

Indexed keywords

EID: 70449556181     PISSN: None     EISSN: 19922248     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Adetuyibi A, Akinsaya JB, Onadeko BO (1973). Analysis Of The Causes Of Death On The Medical Wards Of UCH, Ibadan (1960- 1973) NMJ. 8(1): 28-34.
2. Attaygalle D, Rodrigo N (2004). New trends in the management of tetanus. Expert Rev. Anti Infec. Ther. pp. 73-84.
3. Attygalle D, Rodrigo N (1997). Magnesium Sulphate For Control Of Spasms In Severe Tetanus. Can We Avoid Sedation And Artificial Ventilation? Anaesthesia pp. 52:956-962
4. Books VB (1965). Asanuma H. Pharmacological Studies Of Recurrent Cortical Inhibition And Facilitation, Am J. Physiol. 208: 674-681.
5. Cook TM, Prothene RT, Hanael JM (2001). Tetanus: A Review Of Literature B.J.A. 87(3): 477-487.
6. Dietz V, Galazka A, van Loon F, Cochi S (1996). Performance and potency of tetanus toxoid, implications for eliminating neonatal tetanus;Bull. World Health Organization. 74(6): 619-628.
7. Edlich RF, Winters KL, Britt L, Long WB (2006). Management and prevention of tetanus. Long term eff med. Implants. (13): 139-154.
8. Farrar JJ, Yen LM, Cook T, Fairweather N, Bush N, Parry J, Parry CM (2000) Neurological aspects of tropical disease;Tetanus; J. neurol. Neurosurg. Psychiatr. 69: 292-301.
9. Fawcet WJ, Haxty EJ, Male DA (1999). Magnesium physiology and pharmacology; Brit. J. Anaesth. 83: 302-320.
10. Gergen PJ, McQuillain GM, Kieley M, Ezzati RTM, Sutter RW, Virella GA (1995). A population based serological survey of immunity to tetanus in the United States. N. Engl. J. Med. 332: 761-66.
11. James MFM, Manson EDM (1985). The Use Of Magnesium Sulphate Infusion In The Management Of Very Severe Tetanus. Intensive Care Med. 11: 5-6.
12. Lipman J, James MFM, Ershine J (1987). Plit ML. Eldelman J, Esser JD. Autonomic Dysfunction In Severe Tetanus: Magnesium Sulphate As An Adjunct To Deep Sedation. Crit. Care Med. 15: 987-988.
13. Mellanby J (1968). The Effect Of Glutamate On Toxin Production Clostridium Tetani. J. Gen. Microbial. 54: 77-82.
14. Ogun SA, Adelowo OO, Familoni OB (2000). Pattern And Outcome Of Medical Admissions At The Ogun State University Teaching Hospital Sagamu. A Three Year Review: West Afr. J. Med. 19: 304-308.
15. Osuntokun BO, Ogunniyi O (1993). Epidemiology Of Neurological Illness In African edition pp. 8-9.
16. Prys-Roberts C, Kerr JH, Corbett JL, Cramptom SA, Spalding JM (1969). Treatment of Sympathetic Overactivity In Tetanus. Lancet. I: 542-546.
17. Sandford JP (1995). Tetanus forgotten but not gone. N. Engl. J. Med. 332: 812-813.
18. Towey R (2005). Tetanus, Physiol. J. 17: 1-24.
19. Valve P, Vera L (1993). Intracellular Mg and inositor 1,4,5, triphosphate receptor;molecular mechanism of interaction, physiology and pharmacology, Magne Res. 6: 267-274.
20. Witlin AG, Sibai BM (1998). Magnesium Sulphate Therapy In: Preeclampsia And Eclampsia. Obs. Gyn. 92: 883-889.
21. Writght DK, Lalloo UG, Nayaiger S, Govender P (1989). Autonomic Nervous System Dysfunction In: Severe Tetanus: Current Perspectives. Crit. Care Med. 17: 371-375.